Financials Neofect Co.,Ltd

Equities

A290660

KR7290660000

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. 06:00:00 2024-05-07 pm EDT 5-day change 1st Jan Change
1,165 KRW -0.34% Intraday chart for Neofect Co.,Ltd -1.60% -6.28%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 87,967 62,877 65,321 59,271 26,841 43,529
Enterprise Value (EV) 1 70,482 73,398 75,356 77,640 53,246 58,894
P/E ratio -5.73 x -3.96 x -2.99 x -11.7 x -2.79 x -6.06 x
Yield - - - - - -
Capitalization / Revenue 15.6 x 5.11 x 3.51 x 2.56 x 1.02 x 1.64 x
EV / Revenue 12.5 x 5.96 x 4.05 x 3.35 x 2.03 x 2.21 x
EV / EBITDA -15.3 x -6.2 x -6.56 x -17.2 x -11.5 x 143 x
EV / FCF -6.86 x -6.83 x -8.69 x -10.9 x -10.4 x 17.3 x
FCF Yield -14.6% -14.6% -11.5% -9.16% -9.6% 5.79%
Price to Book 3.11 x 5.07 x 4.29 x 4.8 x 4.14 x 1.33 x
Nbr of stocks (in thousands) 11,824 11,931 18,906 18,906 19,241 35,019
Reference price 2 7,440 5,270 3,455 3,135 1,395 1,243
Announcement Date 4/1/19 3/20/20 3/23/21 3/22/22 3/22/23 3/21/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 5,653 12,311 18,625 23,158 26,202 26,614
EBITDA 1 -4,621 -11,829 -11,483 -4,525 -4,611 411.4
EBIT 1 -5,239 -13,649 -14,398 -8,046 -7,537 -1,995
Operating Margin -92.67% -110.87% -77.3% -34.75% -28.77% -7.5%
Earnings before Tax (EBT) 1 -9,634 -16,027 -15,461 -4,594 -9,514 -5,578
Net income 1 -9,634 -15,845 -15,007 -5,045 -9,621 -4,963
Net margin -170.43% -128.7% -80.58% -21.78% -36.72% -18.65%
EPS 2 -1,299 -1,330 -1,156 -266.8 -500.4 -205.0
Free Cash Flow 1 -10,281 -10,744 -8,676 -7,112 -5,113 3,410
FCF margin -181.86% -87.27% -46.58% -30.71% -19.52% 12.81%
FCF Conversion (EBITDA) - - - - - 829.04%
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/1/19 3/20/20 3/23/21 3/22/22 3/22/23 3/21/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 10,522 10,035 18,368 26,406 15,365
Net Cash position 1 17,485 - - - - -
Leverage (Debt/EBITDA) - -0.8895 x -0.8739 x -4.06 x -5.727 x 37.35 x
Free Cash Flow 1 -10,281 -10,744 -8,676 -7,112 -5,113 3,410
ROE (net income / shareholders' equity) -174% -75.9% -93.9% -28% -74.9% -27%
ROA (Net income/ Total Assets) -14.2% -20.6% -17.2% -9.11% -9.16% -2.04%
Assets 1 67,864 77,025 87,493 55,397 105,090 242,919
Book Value Per Share 2 2,389 1,040 806.0 654.0 337.0 936.0
Cash Flow per Share 2 1,875 249.0 727.0 125.0 53.20 381.0
Capex 1 4,641 8,282 589 1,186 265 369
Capex / Sales 82.09% 67.27% 3.16% 5.12% 1.01% 1.39%
Announcement Date 4/1/19 3/20/20 3/23/21 3/22/22 3/22/23 3/21/24
1KRW in Million2KRW
Estimates
  1. Stock Market
  2. Equities
  3. A290660 Stock
  4. Financials Neofect Co.,Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW